Genewise detection of variants in MEFV gene using nanopore sequencing
Lilit Ghukasyan1, Gisane Khachatryan1,2, Tamara Sirunyan1,2
1Laboratory of Human Genetics, Institute of Molecular Biology NAS RA, Yerevan, Armenia.
Abstract:
Familial Mediterranean Fever (FMF) is a genetic disorder with complex inheritance patterns and genotype-phenotype associations, and it is highly prevalent in Armenia. FMF typically follows an autosomal recessive inheritance pattern (OMIM: 249100), though it can occasionally display a rare dominant inheritance pattern with variable penetrance (OMIM։134610). The disease is caused by mutations in the MEFV gene, which encodes the pyrin protein. While the 26 most prevalent mutations account for nearly 99% of all FMF cases, more than 60 pathogenic mutations have been identified. In this study, we aimed to develop an affordable nanopore sequencing method for full-length MEFV gene mutation detection to aid in the diagnosis and screening of FMF. We employed a multiplex amplicon sequencing approach, allowing for the processing of up to 12 samples on both Flow cells and Flongle flow cells. The results demonstrated near-complete concordance between nanopore variant calling and qPCR genotypes. Moreover, nanopore sequencing identified additional variants, which were confirmed by whole exome sequencing. Additionally, intronic and UTR variants were detected. Our findings demonstrate the feasibility of full-gene nanopore sequencing for detecting FMF-associated pathogenic variants. The method is cost-effective, with costs comparable to those of the qPCR test, making it particularly suitable for settings with limited laboratory infrastructure. Further clinical validation using larger sample cohorts will be necessary.
Insights
We developed an affordable nanopore sequencing method for detecting Familial Mediterranean Fever (FMF) gene mutations. This cost-effective approach aids FMF diagnosis, especially in resource-limited settings.
Area of Science:
- Genetics
- Molecular Biology
- Bioinformatics
Background:
- Familial Mediterranean Fever (FMF) is a prevalent genetic disorder with complex inheritance.
- Mutations in the MEFV gene cause FMF, with over 60 identified pathogenic variants.
- Accurate and accessible diagnostic methods are crucial for FMF management.
Purpose of the Study:
- To develop a cost-effective nanopore sequencing method for full-length MEFV gene mutation detection.
- To improve FMF diagnosis and screening capabilities, particularly in resource-limited areas.
Main Methods:
- Multiplex amplicon sequencing using nanopore technology on Flow and Flongle cells.
- Comparison of nanopore variant calling with qPCR genotypes.
- Confirmation of identified variants using whole exome sequencing.
Main Results:
- Near-complete concordance between nanopore sequencing and qPCR for FMF genotypes.
- Nanopore sequencing identified additional pathogenic and non-coding (intronic, UTR) variants.
- The method proved feasible for comprehensive MEFV gene mutation detection.
Conclusions:
- Full-gene nanopore sequencing is a viable, cost-effective tool for detecting FMF-associated MEFV variants.
- This method offers a practical alternative to existing diagnostic tests, especially in settings with limited laboratory infrastructure.
- Further clinical validation with larger cohorts is recommended.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
12:42Fluorescence-microscopy Screening and Next-generation Sequencing: Useful Tools for the Identification of Genes Involved in Organelle Integrity
Published on: April 13, 2012
